Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529

Nigro, 1983, Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal, Cancer, 51, 1826, 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L

1996, Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research, Lancet Lond Engl, 348, 1049, 10.1016/S0140-6736(96)03409-5

Ajani, 2008, Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial, JAMA, 299, 1914, 10.1001/jama.299.16.1914

Gunderson, 2012, Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin, J Clin Oncol, 30, 4344, 10.1200/JCO.2012.43.8085

James, 2013, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial, Lancet Oncol, 14, 516, 10.1016/S1470-2045(13)70086-X

Vuong, 2007, Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy, Int J Radiat Oncol Biol Phys, 67, 1394, 10.1016/j.ijrobp.2006.11.038

Salama, 2007, Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience, J Clin Oncol, 25, 4581, 10.1200/JCO.2007.12.0170

Ben-Josef, 2010, Impact of overall treatment time on survival and local control in patients with anal cancer: A pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11, J Clin Oncol, 28, 5061, 10.1200/JCO.2010.29.1351

Pepek, 2010, Intensity-modulated radiation therapy for anal malignancies: A preliminary toxicity and disease outcomes analysis, Int J Radiat Oncol Biol Phys, 78, 1413, 10.1016/j.ijrobp.2009.09.046

Bazan, 2011, Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer, 117, 3342, 10.1002/cncr.25901

Han, 2014, Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer, Int J Radiat Oncol Biol Phys, 90, 587, 10.1016/j.ijrobp.2014.06.061

Call, 2016, Intensity-modulated radiation therapy for anal cancer: Results from a multi-institutional retrospective cohort study, Am J Clin Oncol, 39, 8, 10.1097/COC.0000000000000009

Yates, 2015, Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3-year outcomes at two Sydney institutions, Clin Oncol (R Coll Radiol), 27, 700, 10.1016/j.clon.2015.08.006

Franco, 2016, Locally advanced (T3-T4 or N+) anal cancer treated with simultaneous integrated boost radiotherapy and concurrent chemotherapy, Anticancer Res, 36, 2027

Myerson, 2009, Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas, Int J Radiat Oncol Biol Phys, 74, 824, 10.1016/j.ijrobp.2008.08.070

Kachnic, 2013, RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 86, 27, 10.1016/j.ijrobp.2012.09.023

Kachnic

Seo, 2009, Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients, Int J Radiat Oncol Biol Phys, 75, 143, 10.1016/j.ijrobp.2008.10.046